Format

Send to

Choose Destination
Eur Heart J. 2018 Apr 7;39(14):1131-1143. doi: 10.1093/eurheartj/ehx549.

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia.

Author information

1
Department of Cardiology, Charite Universitätsmedizin Berlin, Berlin Institute of Health (BIH), German Center of Cardiovascular Research (DZHK), Hindenburgdamm 30, 12203 Berlin, Germany.
2
National Institute for Health and Medical Research (INSERM), University of Pierre and Marie Curie, Pitié-Salpêtrière Hospital, Paris, France.
3
European Atherosclerosis Society, Gothenburg, Sweden.
4
Paris-Diderot-Sorbonne University and Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France.
5
Institute of Cardiovascular Research, Ninewells Hospital and Medical School, Dundee, UK.
6
Department of Molecular and Clinical Medicine, University of Gothenburg and Sahlgrenska University Hospital, and Wallenberg Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden.
7
Lipid Clinic, Point Medical, and Department of Cardiology, CHU Dijon-Bourgogne, Dijon, France.
8
Division of Cardiovascular Medicine, Division of Translational Research and Clinical Epidemiology, Wayne State University School of Medicine, Detroit, MI, USA.
9
Department of Internal Medicine III, Martin-Luther-University Halle/Wittenberg, University Hospital, Halle/Saale, Germany.
10
Trinity College, Dublin, Ireland.
11
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
12
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
13
University Heart Center, Department of Cardiology, University Hospital Zurich, and Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.
14
Heart Failure Unit, Cardiac Department, G Da Saliceto Hospital, Piacenza, Italy.
15
Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College, London, UK.
16
Sahlgrenska University Hospital, Gothenburg, Sweden.
17
Department of Cardiology, Swiss Cardiovascular Center Bern, Bern University Hospital, Bern, Switzerland.
18
Department of Cardiology, University Hospital Ramón y Cajal, Madrid, Spain.
19
Cardiology Department, CCUL, CAML, Faculdade de Medicina, Universidade de Lisboa, Portugal.
20
Department of Cardiology, Hacettepe University, Ankara, Turkey.
21
Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
22
Department of Pharmacological and Biomolecular Sciences, University of Milan and Multimedica IRCSS Milano, Italy.
PMID:
29045644
DOI:
10.1093/eurheartj/ehx549

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center